We are live on ! Find out more
GNTA

Genenta Science
GNTA

4 hedge funds and large institutions have $1.42M invested in Genenta Science in 2024 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.05% more ownership

Funds ownership: 1.93% → 1.97% (+0.05%)

4% less capital invested

Capital invested by funds: $1.48M → $1.42M (-$51.7K)

20% less funds holding

Funds holding: 5 → 4 (-1)

50% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 2

Holders
4
Holders Change
-1
Holders Change %
-20%
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
+$57.1K

Top Sellers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
-$7.95K
2
Morgan Stanley
Morgan Stanley
New York
-$2.13K
Name Holding Trade Value Shares
Change 		Change in
Stake
AG
1
AlTi Global
New York
$753K – – –
A
2
Allianz
Germany
$444K – – –
AU
3
Algebris (UK)
United Kingdom
$181K – – –
Citadel Advisors
4
Citadel Advisors
Florida
$46.5K +$57.1K +11,167 New
UBS Group
5
UBS Group
Switzerland
– -$7.95K -1,862 Closed
Morgan Stanley
6
Morgan Stanley
New York
– -$2.13K -500 Closed

GNTA Hedge Fund Activity: Q4 2024 in Review

4 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in Genenta Science (GNTA) for Q4 2024, worth a combined $1.42M — down 3.5% from $1.48M a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of GNTA and 1 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.

The largest buyer was Citadel Advisors, opening a new position worth an estimated $57.1K. The largest seller was UBS Group, exiting entirely with an estimated $7.95K sold.

  • 4 institutional investors held Genenta Science (GNTA) as of Q4 2024, down from 5 in Q3 2024.
  • Funds reported $1.42M of Genenta Science stock for Q4 2024, down 3.5% quarter-over-quarter.
  • 1 fund opened new Genenta Science positions in Q4 2024 and 2 closed out, a net change of -1 holder.
  • The largest Genenta Science buyer in Q4 2024 was Citadel Advisors, an estimated $57.1K added.
  • The largest Genenta Science seller in Q4 2024 was UBS Group, an estimated $7.95K sold.

Based on aggregated 13F filings for Q4 2024.